Issuer Information

EDGAR: Contact Information
  • Name:
    Bellerophon Therapeutics, Inc.
  • Address:
    184 LIBERTY CORNER ROAD, SUITE 302
    WARREN, NEW JERSEY 07059
  • Phone:
    908-574-4770
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Within 5 years (2013)
  • Previous Names:
    Bellerophon Therapeutics LLC

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
248082: 0001600132-17-000114
First Sale: 2017-09-29
Security Type(s): Equity
Offer Amount: $23,437,050
Amount Sold: $23,437,050
06b

CA, NJ,

238831: 0001600132-17-000054
First Sale: 2017-05-09
Offer Amount: $1,612,500
Amount Sold: $1,612,500
06b No Notices in EFD for this offering.
98191: 0001600132-14-000003
First Sale: 2014-06-20
Offer Amount: $1
Amount Sold: $1
06b No Notices in EFD for this offering.
90265: 0001600132-14-000001
First Sale: 2014-02-10
Offer Amount: $1
Amount Sold: $1
06b No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.